Page last updated: 2024-08-21

malondialdehyde and Bowel Diseases, Inflammatory

malondialdehyde has been researched along with Bowel Diseases, Inflammatory in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's5 (19.23)29.6817
2010's16 (61.54)24.3611
2020's4 (15.38)2.80

Authors

AuthorsStudies
Ahmad, R; Dhawan, P; Duryee, MJ; Eichele, DD; Hunter, CD; Mitra, A; Rosen, MJ; Singh, AB; Singh, S; Smith, LM; Talmon, GA; Thiele, GM1
Adeghate, E; Amir, N; Bastaki, SMA; Ojha, S1
Chen, S; Hu, S; Li, W; Liu, Q; Ma, X; Tang, J; Wei, P; Zeng, J; Zhao, M1
Angelucci, F; Antonioli, L; Benvenuti, L; Bertani, L; Blandizzi, C; Colucci, R; Coviello, V; D'Antongiovanni, V; Di Salvo, C; Fornai, M; Giusti, L; Ha, QTK; Haskó, G; La Motta, C; Németh, ZH; Oh, WK; Pellegrini, C; Quattrini, L; Ronci, M; Semeghini, G; Zallocco, L1
Merwid-Ląd, A; Szandruk, M; Szeląg, A1
Dudzińska, E; Gil-Kulik, P; Gryzinska, M; Kocki, J; Ognik, K1
Liu, X; Xu, X; Yu, X; Zhang, X1
Cavallini, DCU; Celiberto, LS; Pinto, RA; Rossi, EA; Vallance, BA1
Byrav D S, P; Chakrabarti, A; Khanduja, KL; Medhi, B; Prakash, A; Vaiphei, K1
Datta, S; De, AK; Mukherjee, A; Sana, S1
Barbosa, JS; Brito, GA; Correia, ES; Fernandes, GC; Goes, AC; Guimaraes, SB; Lima Júnior, RC; Pinto, FM; Ribeiro, RA; Rodrigues, LV1
Smith, D; Španěl, P1
Geng, Y; Lu, Z; Qin, M; Shi, JS; Xu, H; Xu, X; Xu, ZH1
Agrogiannis, G; Burris, DL; Butt, Z; DeLucca, JF; Dhoble, SJ; Douvi, G; Elliott, DM; Geiger, R; Gikas, A; Hollinger, KR; Hottor, HT; Jiang, W; Li, X; Little, SJ; Marohn, M; McCaskill, ML; Mehta, SR; Moore, AC; Papalois, A; Patel, RV; Pathak, MS; Patsouris, E; Rai, VK; Rais, R; Rathaiah, M; Rojas, C; Sapkota, M; Singh, N; Singh, PK; Singh, V; Slusher, BS; Smith, DM; Stathis, M; Syrmos, N; Thomas, AG; Triantafillidis, J; Vagianos, C; Venkatramu, V; Vornov, JJ; Wozniak, KM; Wyatt, TA; Zhai, H1
Medhi, B; Pandhi, P; Prakash, O; Saikia, UN1
Hasan, F; Khan, I; Siddique, I1
Byrav, DS; Chakrabarti, A; Khanduja, KL; Medhi, B; Vaiphei, K1
Alican, I; Aydin, MS; Ercan, F; Karakoyun, B; Ogunc, AV; Uslu, U; Yuksel, M1
Akarsu, M; Akman, T; Akpinar, H; Resmi, H; Sezer, E; Taylan, E1
Gaikwad, PS; Otari, KV; Shete, RV; Upasani, CD1
Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M1
Achitei, D; Balan, G; Ciobica, A; Gologan, E; Stanciu, C; Stefanescu, G1
Bartsch, H; Nair, J1
Berge, RK; Berstad, A; Erichsen, K; Grimstad, T; Hausken, T; Ulvik, RJ1
Belogi, L; Cavallo, G; Croce, C; Guida, G; Modesti, A; Santiangeli, C; Tubaro, E1
Britti, D; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Mazzon, E; McDonald, MC; Mota-Filipe, H; Terranova, ML; Thiemermann, C1

Reviews

1 review(s) available for malondialdehyde and Bowel Diseases, Inflammatory

ArticleYear
Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review.
    Inflammopharmacology, 2022, Volume: 30, Issue:6

    Topics: Animals; Antioxidants; Glutathione; Inflammatory Bowel Diseases; Malondialdehyde; Nitric Oxide; Oxidative Stress; Quercetin

2022

Trials

1 trial(s) available for malondialdehyde and Bowel Diseases, Inflammatory

ArticleYear
Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
    Alimentary pharmacology & therapeutics, 2005, Nov-01, Volume: 22, Issue:9

    Topics: Adolescent; Adult; Aged; Antioxidants; Biomarkers; Dinoprost; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Iron Deficiencies; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Tablets; Vasoconstrictor Agents

2005

Other Studies

24 other study(ies) available for malondialdehyde and Bowel Diseases, Inflammatory

ArticleYear
Identification of Immunoglobulin G Autoantibody Against Malondialdehyde-Acetaldehyde Adducts as a Novel Serological Biomarker for Ulcerative Colitis.
    Clinical and translational gastroenterology, 2022, 04-01, Volume: 13, Issue:4

    Topics: Acetaldehyde; Adult; Autoantibodies; Biomarkers; Child; Colitis, Ulcerative; Crohn Disease; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Malondialdehyde

2022
Lycopodium Mitigates Oxidative Stress and Inflammation in the Colonic Mucosa of Acetic Acid-Induced Colitis in Rats.
    Molecules (Basel, Switzerland), 2022, Apr-26, Volume: 27, Issue:9

    Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Colitis; Colitis, Ulcerative; Cytokines; Glutathione; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukocyte L1 Antigen Complex; Lycopodium; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar

2022
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
    International journal of molecular sciences, 2021, Jun-13, Volume: 22, Issue:12

    Topics: AMP-Activated Protein Kinases; Animals; Benzofurans; Body Weight; Cell Line; Colon; Dinitrofluorobenzene; Drug Development; Electrophoresis, Gel, Two-Dimensional; Enzyme Activators; Gene Ontology; Inflammatory Bowel Diseases; Interleukin-10; Male; Malondialdehyde; Mice; Organ Size; Phosphorylation; Rats, Sprague-Dawley; Spleen; Tumor Necrosis Factor-alpha

2021
The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
    Inflammopharmacology, 2018, Volume: 26, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Cytokines; Disease Models, Animal; Inflammation Mediators; Inflammatory Bowel Diseases; Iridaceae; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Xanthones

2018
Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Adult; Aged; Antioxidants; Female; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species

2018
The protective effects of Poria cocos-derived polysaccharide CMP33 against IBD in mice and its molecular mechanism.
    Food & function, 2018, Nov-14, Volume: 9, Issue:11

    Topics: Animals; Chromatography, High Pressure Liquid; Colon; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acid-Binding Proteins; Haptoglobins; Hydroxymethylglutaryl-CoA Synthase; Inflammatory Bowel Diseases; Male; Malondialdehyde; Metabolomics; Mice; N-Acetylgalactosaminyltransferases; Peroxidase; Polysaccharides; Proteomics; Sulfasalazine; Tandem Mass Spectrometry; Trinitrobenzenesulfonic Acid; Wolfiporia

2018
Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics.
    Nutrients, 2018, Nov-05, Volume: 10, Issue:11

    Topics: Animals; Bifidobacterium; Biomarkers; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Gastrointestinal Microbiome; Inflammation; Inflammatory Bowel Diseases; Intestines; Lactobacillus; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Peroxidase; Probiotics

2018
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Malondialdehyde; Peroxidase; Pioglitazone; PPAR gamma; Rats; Sulfasalazine; Thiazolidinediones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2013
Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.
    Journal of microencapsulation, 2014, Volume: 31, Issue:8

    Topics: Animals; Cholagogues and Choleretics; Colon; Drug Carriers; Inflammatory Bowel Diseases; Male; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Peroxidase; Rats; Rats, Wistar; Ursodeoxycholic Acid

2014
Electroacupuncture ameliorates experimental colitis induced by TNBS through activation of interleukin-10 and inhibition of iNOS in mice.
    Acta cirurgica brasileira, 2014, Volume: 29, Issue:12

    Topics: Acupuncture Points; Animals; Anti-Inflammatory Agents; Colitis; Colon; Disease Models, Animal; Electroacupuncture; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; Male; Malondialdehyde; Mice; Nitric Oxide Synthase Type II; Peroxidase; Random Allocation; Trinitrobenzenesulfonic Acid

2014
Status of selected ion flow tube MS: accomplishments and challenges in breath analysis and other areas.
    Bioanalysis, 2016, Volume: 8, Issue:11

    Topics: Acetonitriles; Biomarkers; Breath Tests; Colorectal Neoplasms; Equipment Design; Feces; Humans; Inflammatory Bowel Diseases; Malondialdehyde; Mass Spectrometry; Volatile Organic Compounds

2016
Anti-Inflammatory Effects of Ethanol Extract of Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), in Mice with Ulcerative Colitis.
    International journal of medicinal mushrooms, 2016, Volume: 18, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Basidiomycota; Colitis, Ulcerative; Colon; Complex Mixtures; Disease Models, Animal; Humans; Inflammation; Inflammatory Bowel Diseases; Interleukin-1beta; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2016
    Journal of tribology, 2016, Volume: 138, Issue:4

    Topics: Adalimumab; Anemia; Animals; Anti-Inflammatory Agents; Colon; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Iron; Male; Malondialdehyde; Patient Outcome Assessment; Psychometrics; Rats; Rats, Wistar; Self Report; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2016
Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 103, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2008
Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Blotting, Western; Case-Control Studies; Colitis, Ulcerative; Colon; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Interleukin-1beta; Male; Malondialdehyde; Middle Aged; Peroxidase; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Sodium Chloride; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha; Water

2009
Comparative evaluation of different doses of green tea extract alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camellia sinensis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Peroxidase; Plant Extracts; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2011
The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis.
    Life sciences, 2011, Sep-12, Volume: 89, Issue:11-12

    Topics: Animals; Apoptosis; Colitis; Female; Glutathione; Inflammatory Bowel Diseases; Interleukin-10; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Peroxidase; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sildenafil Citrate; Sulfones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2011
Erythrocyte deformability and oxidative stress in inflammatory bowel disease.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:2

    Topics: Adult; Erythrocyte Deformability; Erythrocytes; Female; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Prospective Studies

2012
Protective effect of aqueous extract of Spinacia oleracea leaves in experimental paradigms of inflammatory bowel disease.
    Inflammopharmacology, 2012, Volume: 20, Issue:5

    Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis; Female; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Mice; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Wistar; Spinacia oleracea

2012
Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.
    Inflammation, 2012, Volume: 35, Issue:3

    Topics: Acetic Acid; Animals; Colitis; Colon; Cyclooxygenase 2; Heme Oxygenase-1; Inflammatory Bowel Diseases; Interleukin-6; Male; Malondialdehyde; Nadroparin; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2012
Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:5

    Topics: Adult; C-Reactive Protein; Case-Control Studies; Female; Glutathione Peroxidase; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Superoxide Dismutase; Young Adult

2013
Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies.
    Mutation research, 2005, Dec-11, Volume: 591, Issue:1-2

    Topics: Aldehydes; Cross-Linking Reagents; DNA Adducts; DNA Damage; Ethanol; Humans; Inflammation; Inflammatory Bowel Diseases; Lipid Peroxidation; Liver; Malondialdehyde; Molecular Structure; Neoplasms; Oxidative Stress; Pancreatitis, Chronic; Risk Factors

2005
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.
    Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 348, Issue:6

    Topics: Animals; Arachidonic Acid; Carbohydrate Sequence; Colitis; Colon; Gangliosides; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Male; Malondialdehyde; Molecular Sequence Data; Organ Size; Pancreas; Peroxidase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Spleen; Synovial Fluid; Trinitrobenzenesulfonic Acid

1993
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
    Gut, 2001, Volume: 48, Issue:4

    Topics: Adenosine Diphosphate Ribose; Analysis of Variance; Animals; Cysteine Proteinase Inhibitors; Dinitrobenzenes; Glycoproteins; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; P-Selectin; Peroxidase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonic Acids; Tyrosine; Up-Regulation

2001